Ipca Laboratories Limited entered into a Technology Transfer Agreement with Omexa Formulary Pvt. Ltd. . (Omexa) for a biosimilar clone, process development and knowledge transfer for the global market.

Under this Agreement, lpca will grant to Omexa a non-exclusive right to research, develop, manufacture and market a anti-cancer biosimilar for global market. This Agreement shall enable Omexa to develop this anti-cancer biosimilar from early stage of to clinical trials and subsequent commercial launch. This agreement will also strengthen Omexa's capability of biosimilar development.